America's overdose crisis shows sustained decline
Built WorldDrug overdose deaths have fallen for three straight years—but federal funding cuts and a new potent adulterant now threaten that progress
May 13th, 2026: CDC Projects ~70,000 Deaths for Full Year 2025—Third Straight DeclineNew here? Follow stories to track developments over time. Create a free account to get updates when stories you care about change.
Overview
Updated May 23U.S. overdose deaths fell for the third straight year in 2025. CDC provisional data released May 2026 projects 69,973 deaths for the full year—down 14% from 2024 and about 38% below the 2022 peak of 112,000.
In April 2026, the Trump administration banned federal funding for fentanyl test strips, overturning prior policy. Medetomidine, a veterinary sedative 300 times more potent than xylazine and not reversible by naloxone, is now spreading through drug supplies in Chicago, Philadelphia, and Pittsburgh. Several western states—Arizona, New Mexico, Colorado—are seeing deaths climb again.
Why it matters
Drug overdoses kill more Americans under 45 than any other cause—and new federal cuts are testing whether three years of progress hold.
Questions about this story
Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.
No questions yet — be the first to ask.
Key Indicators
Voices
Curated perspectives — historical figures and your fellow readers.
Play
Exploring all sides of a story is often best achieved with Play.
Higher or Lower
A number from this story, against one from elsewhere in the news — guess which is bigger, then keep the chain going. 5 rounds, 3 strikes; a miss costs a strike and resets your streak.
Keyboard: ↓/L lower · ↑/H higher
0 points — sign up to put that on the leaderboard.
Timeline
Order five events from this story, oldest at top. Each in the right slot scores 1 — neighbours within one slot count too. Your previous result — green ✓ for exact slots, yellow ~ for off by one. Cards now in true chronological order.
Sign up to save your score and track a streak across stories.
Connections
Sixteen names from the news. Find the four hidden groups of four. Four mistakes max.
Sign up to keep a daily streak — a new puzzle lands every day.
Exit debate?
Your progress in this debate will be lost.
- 1 Two AI personas square off on this story.
- 2 You predict who'll win each round — correct picks earn XP.
- 3 One crossfire question is yours to fire. Pick it carefully.
Couldn't generate a topic
Select Your Champions
Choose one persona for each side of the debate
DEBATE TOPIC
Choose personas with different perspectives for a more dynamic debate.
Select debater for this side:
No debate personas available right now.
Select debater for this side:
No debate personas available right now.
Who's Got This Round?
Make your prediction before the referee scores
The referee scores both sides on
Round Results
Set the Crossfire
Pick the question both personas must answer in the final round
Debate Oracle! You called every round!
Sharp Instincts! You know your debaters!
The Coin Flip Strategist! Perfectly balanced!
The Contrarian! Bold predictions!
Inverse Genius! Try betting the opposite next time!
XP Breakdown
Prediction History
People Involved
Organizations Involved
Federal agency tracking overdose deaths through the National Vital Statistics System, providing provisional monthly data used to measure crisis trends.
White House office coordinating the $44 billion federal drug budget across 19 agencies and setting national drug control priorities.
Federal agency that distributes block grants and direct grants for addiction treatment, harm reduction, and mental health services nationwide. In 2026 it became a focal point for the administration's shift away from harm reduction.
Timeline
January 1999 May 2026
-
CDC Projects ~70,000 Deaths for Full Year 2025—Third Straight Decline
Latest Data ReleaseProvisional data released by CDC's National Vital Statistics System shows approximately 69,973 overdose deaths for all of 2025, down 14% from 2024. The decline continues but has slowed sharply from the 27% drop recorded the year before.
-
SAMHSA Bans Federal Funding for Fentanyl Test Strips
PolicySAMHSA guidance prohibits federal grant funds from purchasing fentanyl test strips and other drug-checking supplies—reversing prior policy. Organizations distributing hundreds of thousands of strips quarterly now face funding gaps.
-
CDC Warns of Medetomidine Spreading Through Illicit Drug Supply
Emerging ThreatCDC issued a health alert warning that medetomidine—a veterinary sedative up to 300 times more potent than xylazine—is replacing xylazine in parts of Chicago, Philadelphia, and Pittsburgh. Naloxone does not reverse its effects, and abrupt withdrawal can be life-threatening.
-
Trump Administration Reverses $2 Billion SAMHSA Grant Cuts After 24-Hour Backlash
PolicyOne day after abruptly terminating roughly $2 billion in addiction and mental health grants to about 2,000 organizations, the Trump administration reversed the cuts following immediate legal and political pressure.
-
CDC Reports 21% Decline Through August 2025
Data ReleaseNew provisional data predicts 72,836 overdose deaths for 12 months ending August 2025. Decline continues for second consecutive year, though rate of decrease has slowed. Deaths down in 45 states.
-
$7.4 Billion Purdue/Sackler Settlement Finalized
LegalNew York AG announces landmark settlement with Purdue Pharma and Sackler family. Sacklers pay up to $6.5 billion over 15 years; Purdue contributes $900 million. Largest individual opioid settlement.
-
CDC Reports 27% Annual Decline—Largest Ever
Data ReleaseProvisional data shows approximately 80,000 deaths in 12 months ending early 2024, down from 110,000 the previous year. Largest single-year reduction in overdose deaths ever recorded.
-
Biden-Xi Summit Revives Fentanyl Cooperation
DiplomaticU.S. and China agree to resume counternarcotics cooperation frozen since 2019. China shuts down some precursor suppliers and resumes sharing suspicious shipment data with international authorities.
-
Overdose Deaths Begin Sustained Decline
Turning PointCDC data identifies August 2023 as inflection point when national overdose death rates reversed course. Deaths decline for 15 consecutive months—the longest sustained drop in decades.
-
White House Declares Xylazine Emerging Threat
PolicyONDCP designates fentanyl mixed with xylazine ('tranq') as emerging drug threat. The veterinary sedative, found in 30% of seized fentanyl, doesn't respond to naloxone and causes severe wounds.
-
FDA Approves Over-the-Counter Naloxone
PolicyNarcan nasal spray approved for sale without prescription in pharmacies, convenience stores, and online. First OTC naloxone product in U.S. history, removing barrier to overdose reversal medication.
-
X-Waiver Eliminated for Buprenorphine
PolicyConsolidated Appropriations Act removes requirement for special waiver to prescribe addiction treatment medication. Any provider with DEA Schedule III authority can now prescribe buprenorphine, expanding treatment access.
-
Overdose Deaths Peak at 112,000
MilestoneAnnual overdose deaths hit all-time high of 112,109 Americans—more than car accidents, gun violence, or any single disease for those under 45. Fentanyl involved in roughly 70% of deaths.
-
China Imposes Class-Wide Fentanyl Controls
PolicyUnder U.S. pressure, China schedules all fentanyl-related substances as controlled. Direct fentanyl shipments to U.S. largely cease, but precursor chemical trade to Mexican cartels continues.
-
Wave Three: Synthetic Opioids Transform Crisis
EscalationIllicitly manufactured fentanyl enters drug supply. Fifty times more potent than heroin, it causes deaths to accelerate dramatically. By 2017, synthetic opioids become leading driver of overdose deaths.
-
Wave Two: Heroin Deaths Spike
EscalationAs prescription opioid restrictions tighten, users shift to cheaper heroin flooding in from Mexico. Heroin overdose rate increases fivefold between 2010 and 2016.
-
Wave One Begins: Prescription Opioid Deaths Rise
OriginCDC identifies start of opioid overdose epidemic, driven by aggressive marketing of OxyContin and other prescription painkillers. Deaths from prescription opioids begin steady climb that will continue for over two decades.
Historical Context
3 moments from history that rhyme with this story — and how they unfolded.
Crack Cocaine Epidemic Response (1980s-1990s)
Crack cocaine spread rapidly through American cities, causing hospital emergencies to surge from 23,500 to 94,000 between 1984 and 1987. Congress responded with the Anti-Drug Abuse Act of 1986, creating 100:1 sentencing disparity between crack and powder cocaine.
Federal prison population for drug offenses exploded from 50,000 in 1980 to 400,000 by 1997. Black communities, comprising 80% of crack users, bore disproportionate impact.
Mass incarceration devastated communities without reducing drug use. The punitive approach is now widely viewed as a failure, influencing current emphasis on treatment over imprisonment.
The crack response shows consequences of treating addiction as primarily a criminal matter. The relative decline in opioid deaths coincides with policy shift toward public health approaches—though enforcement remains substantial, treatment and harm reduction now receive significant resources.
AIDS Crisis Harm Reduction (1980s-1990s)
As HIV spread among injection drug users, activists pioneered needle exchange programs over fierce political opposition. First U.S. syringe exchange opened in Tacoma in 1988. Federal funding for such programs was banned from 1988 to 2016.
Cities with syringe exchanges saw HIV transmission among drug users drop by 50-80%. Programs also connected users to treatment and healthcare.
Research established harm reduction as evidence-based public health. Federal funding ban lifted in 2016. By 2024, syringe services operate in most states and serve as distribution points for naloxone and fentanyl test strips.
Current overdose decline builds on harm reduction infrastructure developed during AIDS crisis. Naloxone distribution often occurs through syringe services. The path from controversial intervention to mainstream policy took decades—fentanyl test strip legalization followed similar trajectory in compressed timeframe.
Portugal Drug Decriminalization (2001)
Facing Europe's worst heroin crisis—1% of the population addicted—Portugal decriminalized personal drug possession and redirected 90% of drug enforcement spending to health services. Police refer users to 'dissuasion commissions' offering voluntary treatment rather than arrest.
HIV infections from injection drug use dropped 90%. Overdose deaths fell from 80 per million to 6 per million by 2021—a 93% reduction.
Portugal now has Europe's lowest overdose rate, one-fiftieth of the U.S. rate. The model influenced drug policy debates worldwide, though recent disinvestment has caused some backsliding.
Portugal demonstrates that health-centered drug policy can produce sustained mortality reductions. The U.S. decline incorporates some elements—expanded treatment, harm reduction—but without decriminalization and with far less funding relative to need.
